CFAP95
gene geneOn this page
Summary
CFAP95 (cilia and flagella associated protein 95, HGNC:31422) is a protein-coding gene on chromosome 9q21.12, encoding Cilia- and flagella-associated protein 95 (Q5VTT2). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Predicted to be involved in flagellated sperm motility. Located in axonemal microtubule and plasma membrane.
Source: NCBI Gene 138255 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 11 total
- MANE Select transcript:
NM_001010940
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31422 |
| Approved symbol | CFAP95 |
| Name | cilia and flagella associated protein 95 |
| Location | 9q21.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000204711 |
| Ensembl biotype | protein_coding |
| Entrez | 138255 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 6 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000377197, ENST00000466872, ENST00000480564, ENST00000495399, ENST00000527647, ENST00000529131, ENST00000529446, ENST00000936456, ENST00000936457, ENST00000936458
RefSeq mRNA: 4 — MANE Select: NM_001010940
NM_001010940, NM_001308084, NM_001308085, NM_001308086
CCDS: CCDS35041, CCDS78403
Canonical transcript exons
ENST00000377197 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001473067 | 69905954 | 69906227 |
| ENSE00001473072 | 69844517 | 69844625 |
| ENSE00001473074 | 69820817 | 69821031 |
| ENSE00003515718 | 69856555 | 69856673 |
| ENSE00003528405 | 69886838 | 69886895 |
| ENSE00003639731 | 69857909 | 69857977 |
Expression profiles
Bgee: expression breadth ubiquitous, 153 present calls, max score 99.28.
FANTOM5 (CAGE): breadth broad, TPM avg 2.5293 / max 151.9756, expressed in 287 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 96847 | 1.6418 | 265 |
| 96848 | 0.8875 | 115 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 99.28 | gold quality |
| bronchus | UBERON:0002185 | 98.82 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.84 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 94.04 | gold quality |
| sperm | CL:0000019 | 92.87 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 92.60 | gold quality |
| right uterine tube | UBERON:0001302 | 92.09 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 90.14 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 89.26 | gold quality |
| oviduct epithelium | UBERON:0004804 | 87.21 | gold quality |
| pituitary gland | UBERON:0000007 | 85.47 | gold quality |
| trachea | UBERON:0003126 | 84.41 | gold quality |
| fallopian tube | UBERON:0003889 | 83.62 | gold quality |
| left testis | UBERON:0004533 | 83.33 | gold quality |
| right testis | UBERON:0004534 | 82.68 | gold quality |
| adenohypophysis | UBERON:0002196 | 82.49 | gold quality |
| testis | UBERON:0000473 | 81.84 | gold quality |
| islet of Langerhans | UBERON:0000006 | 80.54 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 80.39 | gold quality |
| caput epididymis | UBERON:0004358 | 79.08 | gold quality |
| body of tongue | UBERON:0011876 | 78.23 | gold quality |
| secondary oocyte | CL:0000655 | 77.48 | gold quality |
| adult organism | UBERON:0007023 | 76.93 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 73.96 | gold quality |
| buccal mucosa cell | CL:0002336 | 73.56 | silver quality |
| biceps brachii | UBERON:0001507 | 72.01 | gold quality |
| right lung | UBERON:0002167 | 70.26 | gold quality |
| tongue | UBERON:0001723 | 67.37 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 66.16 | gold quality |
| endometrium | UBERON:0001295 | 65.27 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 61.83 |
| E-HCAD-1 | yes | 26.59 |
| E-MTAB-10287 | yes | 25.96 |
| E-MTAB-9388 | yes | 11.40 |
| E-MTAB-6524 | no | 70.50 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cfap95 | ENSMUSG00000033053 |
| rattus_norvegicus | Cfap95 | ENSRNOG00000036615 |
Protein
Protein identifiers
Cilia- and flagella-associated protein 95 — Q5VTT2 (reviewed: Q5VTT2)
All UniProt accessions (4): E9PIA3, H0YD79, H0YDM9, Q5VTT2
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules. Interacts with MYH9. Interacts with MYH10.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium axoneme. Flagellum axoneme. Cell membrane.
Tissue specificity. Expressed in undifferentiated embryonic stem cells. Expressed in airway epithelial cells.
Induction. Down-regulated following embryonic stem cells differentiation.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5VTT2-1 | 1 | yes |
| Q5VTT2-2 | 2 |
RefSeq proteins (4): NP_001010940, NP_001295013, NP_001295014, NP_001295015 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027905 | CFAP95 | Family |
Pfam: PF15139
UniProt features (7 total): topological domain 2, chain 1, transmembrane region 1, region of interest 1, glycosylation site 1, splice variant 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7UNG | ELECTRON MICROSCOPY | 3.6 |
| 8J07 | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VTT2-F1 | 63.03 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 75
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 54 (showing top):
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOCC_CYTOPLASMIC_REGION, GOCC_MOTILE_CILIUM, GOCC_CYTOPLASMIC_MICROTUBULE, GOCC_CILIUM, chr9q21, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MIKKELSEN_MEF_ICP_WITH_H3K27ME3, RAO_BOUND_BY_SALL4_ISOFORM_B, GOCC_AXONEMAL_MICROTUBULE, GOCC_9PLUS2_MOTILE_CILIUM, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER
GO Biological Process (1): flagellated sperm motility (GO:0030317)
GO Molecular Function (0):
GO Cellular Component (10): cytoplasm (GO:0005737), axonemal microtubule (GO:0005879), plasma membrane (GO:0005886), sperm flagellum (GO:0036126), axonemal A tubule inner sheath (GO:0160111), cytoskeleton (GO:0005856), cilium (GO:0005929), membrane (GO:0016020), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| intracellular anatomical structure | 1 |
| cytoplasmic microtubule | 1 |
| axoneme | 1 |
| membrane | 1 |
| cell periphery | 1 |
| 9+2 motile cilium | 1 |
| A axonemal microtubule | 1 |
| axonemal microtubule doublet inner sheath | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
662 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP95 | MORN5 | Q5VZ52 | 639 |
| CFAP95 | ATP6V0D2 | Q8N8Y2 | 498 |
| CFAP95 | FAM219A | Q8IW50 | 479 |
| CFAP95 | DPP6 | P42658 | 463 |
| CFAP95 | DRICH1 | Q6PGQ1 | 448 |
| CFAP95 | PPDPFL | Q8WWR9 | 413 |
| CFAP95 | TPRG1 | Q6ZUI0 | 403 |
| CFAP95 | HDDC2 | Q7Z4H3 | 400 |
| CFAP95 | PADI1 | Q9ULC6 | 393 |
| CFAP95 | DPCD | Q9BVM2 | 378 |
| CFAP95 | FHIP2A | Q5W0V3 | 375 |
| CFAP95 | GPR176 | Q14439 | 371 |
| CFAP95 | RSPH14 | Q9UHP6 | 370 |
| CFAP95 | SHC2 | P98077 | 361 |
| CFAP95 | ODF4 | Q2M2E3 | 351 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFAP95 | PB2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A1B0GTD5, A0A1B0GUX0, A0A3Q1MT14, A4D263, A6NL82, A6QQL5, A8QW39, B0UXH9, B5X5D0, B9EJX3, E1B9R1, F1MMV1, Q148A4, Q1JPL0, Q2T9T0, Q32KQ1, Q32L72, Q32L77, Q32P67, Q3V0J4, Q5BN46, Q5NC57, Q5NC83, Q5SPV6, Q5SS90, Q5SVJ3, Q5VTT2, Q5VZQ5, Q66HC0, Q66HR9, Q6AYM0, Q6NXP0, Q6P3G4, Q6ZVS7, Q80X60, Q8CDT5, Q8CDU5, Q8N5S3, Q8N7U6, Q8N865
Diamond homologs: Q32L77, Q5VTT2, Q9CQC3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
11 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 5 |
| Likely benign | 1 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1258 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:69844515:A:G | acceptor_gain | 1.0000 |
| 9:69844622:CCCA:C | donor_gain | 1.0000 |
| 9:69844623:CCA:C | donor_gain | 1.0000 |
| 9:69844626:G:GG | donor_gain | 1.0000 |
| 9:69857978:G:GG | donor_gain | 1.0000 |
| 9:69886896:G:GG | donor_gain | 1.0000 |
| 9:69821029:CTGGT:C | donor_loss | 0.9900 |
| 9:69821030:TGGT:T | donor_loss | 0.9900 |
| 9:69821031:GGT:G | donor_loss | 0.9900 |
| 9:69821032:G:GC | donor_loss | 0.9900 |
| 9:69821032:G:GG | donor_gain | 0.9900 |
| 9:69821033:T:G | donor_loss | 0.9900 |
| 9:69821034:G:GT | donor_loss | 0.9900 |
| 9:69826507:G:GG | donor_gain | 0.9900 |
| 9:69844516:G:A | acceptor_gain | 0.9900 |
| 9:69844516:G:GG | acceptor_gain | 0.9900 |
| 9:69844621:CCCCA:C | donor_gain | 0.9900 |
| 9:69844624:CA:C | donor_gain | 0.9900 |
| 9:69844624:CAGT:C | donor_loss | 0.9900 |
| 9:69844625:AG:A | donor_loss | 0.9900 |
| 9:69844626:GTAAG:G | donor_loss | 0.9900 |
| 9:69844627:T:TG | donor_loss | 0.9900 |
| 9:69844628:AAG:A | donor_loss | 0.9900 |
| 9:69844629:A:AA | donor_loss | 0.9900 |
| 9:69844630:G:C | donor_loss | 0.9900 |
| 9:69856553:A:AG | acceptor_gain | 0.9900 |
| 9:69856554:G:GG | acceptor_gain | 0.9900 |
| 9:69886892:ACATG:A | donor_loss | 0.9900 |
| 9:69886893:CATG:C | donor_loss | 0.9900 |
| 9:69886894:ATG:A | donor_loss | 0.9900 |
AlphaMissense
1502 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:69906008:T:C | F188L | 0.969 |
| 9:69906010:C:A | F188L | 0.969 |
| 9:69906010:C:G | F188L | 0.969 |
| 9:69906050:T:A | W202R | 0.935 |
| 9:69906050:T:C | W202R | 0.935 |
| 9:69906009:T:C | F188S | 0.907 |
| 9:69905992:A:C | R182S | 0.894 |
| 9:69905992:A:T | R182S | 0.894 |
| 9:69906062:A:C | S206R | 0.891 |
| 9:69906064:T:A | S206R | 0.891 |
| 9:69906064:T:G | S206R | 0.891 |
| 9:69821003:T:C | Y42H | 0.872 |
| 9:69906052:G:C | W202C | 0.869 |
| 9:69906052:G:T | W202C | 0.869 |
| 9:69821030:T:A | W51R | 0.868 |
| 9:69821030:T:C | W51R | 0.868 |
| 9:69857934:T:C | F136L | 0.867 |
| 9:69857936:T:A | F136L | 0.867 |
| 9:69857936:T:G | F136L | 0.867 |
| 9:69820970:G:C | G31R | 0.866 |
| 9:69906009:T:G | F188C | 0.866 |
| 9:69844517:G:C | W51C | 0.857 |
| 9:69844517:G:T | W51C | 0.857 |
| 9:69906079:T:A | N211K | 0.853 |
| 9:69906079:T:G | N211K | 0.853 |
| 9:69844536:T:C | F58L | 0.844 |
| 9:69844538:T:A | F58L | 0.844 |
| 9:69844538:T:G | F58L | 0.844 |
| 9:69906002:T:C | S186P | 0.839 |
| 9:69821004:A:C | Y42S | 0.838 |
dbSNP variants (sampled 300 via entrez): RS1000002953 (9:69878159 G>A,C), RS1000050827 (9:69848999 A>G), RS1000063429 (9:69865053 A>G), RS1000121265 (9:69902101 C>T), RS1000140779 (9:69823494 C>T), RS1000156208 (9:69829929 C>T), RS1000172231 (9:69823640 G>A), RS1000220693 (9:69828540 G>A), RS1000268387 (9:69820512 G>GGGGT), RS1000270929 (9:69861057 T>C), RS1000360488 (9:69861004 G>A), RS1000397191 (9:69896146 G>A), RS1000406155 (9:69820184 C>T), RS1000436188 (9:69903110 T>C), RS1000444740 (9:69829549 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005580_253 | Intraocular pressure | 2.000000e-10 |
| GCST005580_71 | Intraocular pressure | 1.000000e-11 |
| GCST009208_5 | Transverse temporal cortex volume | 4.000000e-06 |
| GCST009310_27 | Sensorimotor dexterity | 4.000000e-08 |
| GCST011176_10 | Stroke | 2.000000e-07 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004695 | intraocular pressure measurement |
| EFO:0008354 | cognitive function measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects expression, affects cotreatment | 8 |
| entinostat | increases expression, affects cotreatment | 2 |
| methylmercuric chloride | decreases expression | 1 |
| trichostatin A | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Decitabine | affects expression | 1 |
| Vorinostat | increases expression, affects cotreatment | 1 |
| Panobinostat | affects cotreatment, increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cisplatin | affects expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.